A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
Completed · Phase 3
Conditions studied: Non-Small Cell Lung Cancer
In brief
Taxotere has been approved by the FDA and is considered a standard treatment for patients with lung cancer who have failed prior platinum-containing regimens. The main purpose of this research study is to determine if Aptosyn, when given in combination with Taxotere, will result in prolonged survival when compared to Taxotere alone. This study will also help determine tumor response rates, and the safety profile of Aptosyn in combination with Taxotere. This study has been completed and a publication is pending.
Key facts
- Study ID
- NCT00085826
- Run by
- Astellas Pharma Inc
- People needed
- 600
- Starts
- 2001-04-01
- Expected to finish
- 2004-12-01
- Last updated by the study team
- 2011-10-20
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Birmingham Hematology and Oncology Associates, LLC — Birmingham, Alabama, United States
- Northern Arizona Hematology and Oncology Associates — Flagstaff, Arizona, United States
- Hematology & Oncology Associates — Phoenix, Arizona, United States
- Northern Arizona Hematology & Oncology Associates — Sedona, Arizona, United States
- Arizona Clinical Research Center — Tucson, Arizona, United States
- Arkansas Oncology Associates, PA — Little Rock, Arkansas, United States
- Pacific Coast Hematology/Oncology Medical Group, Inc. — Fountain Valley, California, United States
- California Cancer Care, Inc. — Greenbrae, California, United States
- Scripps Cancer Center — San Diego, California, United States
- Sharp Clinical Oncology Research — San Diego, California, United States
- Redwood Regional Medical Group — Santa Rosa, California, United States
- Rocky Mountain Cancer Center — Boulder, Colorado, United States
- Rocky Mountain Cancer Centers — Colorado Springs, Colorado, United States
- RMCC — Denver, Colorado, United States
- 12. Rocky Mountain Cancer Centers-Englewood — Englewood, Colorado, United States
- Rocky Mountain Cancer Centers — Englewood, Colorado, United States
- Rocky Mountain Cancer Centers — Fort Collins, Colorado, United States
- Rocky Mountain Cancer Centers — Littleton, Colorado, United States
- Rocky Mountain Cancer Centers — Thornton, Colorado, United States
- Boca Raton Comprehensive Cancer Center — Boca Raton, Florida, United States
- Comprehensive Cancer Care Specialists at Boca Raton — Boca Raton, Florida, United States
- North Florida Hematology & Oncology Association — Jacksonville, Florida, United States
- Florida Oncology Associates — Jacksonville, Florida, United States
- South Florida Oncology & Hematology Consultants — Lauderhill, Florida, United States
- Birmingham Hematology Oncology Associates — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.